Published in Am Heart J on December 01, 1976
Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation (1990) 2.05
The natural history of aortic valve stenosis. Eur Heart J (1988) 1.72
Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol (2004) 1.53
Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol (1999) 1.49
Percutaneous coronary interventions using a new 5 French guiding catheter: results of a prospective study. Catheter Cardiovasc Interv (2001) 1.39
Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM). Postgrad Med J (1978) 1.28
Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J (1983) 1.15
Recording of left atrial potentials from pulmonary artery in man. Br Heart J (1980) 1.09
Effects of verapamil on sinus node function in man. Eur J Cardiol (1978) 1.04
Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.00
[Diagnostic and prognostic value of endomyocardial biopsy in patients with congestive cardiomyopathy (author's transl)]rdiomyopathy(author. Dtsch Med Wochenschr (1975) 1.00
Influence of sampling site and flow area on cardiac output measurements by Doppler echocardiography. J Am Coll Cardiol (1987) 0.99
Sinus node recovery time and calculated sinoatrial conduction time in normal subjects and patients with sinus node dysfunction. Circulation (1977) 0.98
The definition of heart failure. Eur Heart J (1983) 0.94
Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation (1998) 0.94
Non-invasive detection of late potentials in man--a new marker for ventricular tachycardia. Eur Heart J (1981) 0.93
Exercise performance in hypertrophic cardiomyopathies. Eur Heart J (1983) 0.93
[Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)]. Z Kardiol (1981) 0.93
Arrhythmias in hypertrophic obstructive and non-obstructive cardiomyopathy. Eur Heart J (1983) 0.91
Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake. Cor Vasa (1985) 0.91
Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J (1983) 0.90
Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation (1983) 0.89
Propafenone--a new antiarrhythmic drug. Eur Heart J (1980) 0.89
[The etiology, course and prognosis of dilated cardiomyopathy]. Z Kardiol (1982) 0.89
[Low-dose enalapril in severe chronic heart failure]. Z Kardiol (1991) 0.89
[Differential diagnosis of cyanosis. Familial methemoglobin-reductase deficiency]. Med Welt (1971) 0.89
Accuracy of Doppler echocardiography in quantification of left to right shunts in adult patients with atrial septal defect. J Am Coll Cardiol (1988) 0.89
Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol (2005) 0.88
Death due to transprosthetic catheterization of a Björk-Shiley prosthesis in the aortic position. Am J Cardiol (1986) 0.88
[Effect of alcohol on the heart including alcoholic cardiomyopathy]. Internist (Berl) (1978) 0.87
Prosthetic valve endocarditis: clinical findings and management. Eur Heart J (1984) 0.87
Molecular and electrophysiological evidence for "remodeling" of the L-type Ca2+ channel in persistent atrial fibrillation in humans. Z Kardiol (2000) 0.87
[Course observations of hypertrophic obstructive myocardiopathy]. Z Kardiol (1976) 0.86
Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris. Circulation (1995) 0.86
[Significance of electrocardiography in the diagnosis and course observation of patients with congestive cardiomyopathy]. Z Kardiol (1974) 0.86
Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol (1996) 0.86
Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia. J Cardiovasc Pharmacol (1981) 0.85
Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation. Am J Cardiol (1990) 0.84
Late outcome of survivors of idiopathic ventricular fibrillation. Am J Cardiol (1998) 0.83
[Effect of flecainide on chronic ventricular arrhythmias (author's transl)]. Z Kardiol (1982) 0.83
Surgical treatment of ventricular tachycardias. Complete versus partial encircling endocardial ventriculotomy. J Thorac Cardiovasc Surg (1984) 0.83
[Which rhythm disturbances react to beta blockaders?]. Cardiology (1978) 0.83
[Cholestasis after antiarrhythmic therapy with propafenone]. Dtsch Med Wochenschr (1984) 0.83
[Twiddler-Syndrome in a subpectoral implanted unipolar cardioverter-defibrillator]. Z Kardiol (1998) 0.82
[Congestive cardiomyopathy]. Med Welt (1973) 0.82
[Obstructive myocardiopathy]. Z Kreislaufforsch (1971) 0.82
Streptokinase-induced activation of the kallikrein-kinin system and of the contact phase in patients with acute myocardial infarction. J Cardiovasc Pharmacol (1998) 0.82
Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol (1999) 0.82
[Hemodynamics of the pulmonary circulation during a multistep exercise test in healthy subjects]. Med Welt (1976) 0.82
Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment. Int J Cardiol (1999) 0.82
Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold. Pacing Clin Electrophysiol (1998) 0.81
Doppler versus contrast echocardiography for diagnosis of tricuspid regurgitation. Am J Cardiol (1985) 0.81
The effect of premature atrial depolarization on sinus node automaticity in man. Circulation (1976) 0.81
Prevalence of late potentials in patients with and without ventricular tachycardia: correlation with angiographic findings. Am J Cardiol (1982) 0.81
[Diagnostic significance of various parameters of sinus node function (author's transl)]. Z Kardiol (1979) 0.81
Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Am J Cardiol (1984) 0.81
[Primary pulmonary hypertension]. Z Kardiol (1976) 0.81
Percutaneous coronary excimer laser angioplasty: initial clinical results. Lancet (1989) 0.81
[Echocardiographic determination of the severity of mitral stenosis by the mitral valve closure index (author's transl)]. Z Kardiol (1979) 0.80
Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction. J Am Coll Cardiol (1998) 0.80
Five-year results after randomized mitral valve replacement with Björk-Shiley. Lillehei-Kaster, and Starr-Edwards prostheses. Thorac Cardiovasc Surg (1983) 0.80
[Indications for coronary angiography in patients with acquired heart valve diseases with reference to risk factors]. Z Kardiol (1987) 0.80
[Blood coagulation and fibrinolysis in arteriosclerosis]. Z Kardiol (1999) 0.80
Ventricular septal defect. Circulation (1968) 0.80
Reoperations for malfunction of heart valve prostheses, especially with endocarditis. Thorac Cardiovasc Surg (1987) 0.79
[Bundle of His extrasystoles as a cause for A-V block and junctional tachycardia (author's transl)]. Z Kardiol (1981) 0.79
Ventricular vulnerability assessed by programmed ventricular stimulation in patients with and without late potentials. Circulation (1983) 0.79
[Quantitative measurement of force and velocity of force development in the apex cardiogram. A new technic]. Z Gesamte Exp Med (1968) 0.79
Selenium and myocardial infarction: glutathione peroxidase in platelets. Klin Wochenschr (1981) 0.79
[Benefits of endocarditis prevention in patients with prosthetic heart valves]. Z Kardiol (1986) 0.79
[Primary pulmonary hypertension. Report of the Commission of the German Society for Research on Blood Circulation]. Verh Dtsch Ges Kreislaufforsch (1972) 0.79
Atrial vulnerability and electrophysiology determined in patients with and without paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1992) 0.79
Comparative study of two methods of estimating sinoatrial conduction time in man. Am J Cardiol (1978) 0.78
[Left bundle-branch block: inferences from ventricular septal motion in the echocardiogram concerning left ventricular function]. Z Kardiol (1983) 0.78
Influence of drugs on the relationship between sinus node recovery time and calculated sinoatrial conduction time in man. Basic Res Cardiol (1978) 0.78
[The clinical significance of the calculated sinoatrial conduction time (SACT) (author's transl)]. Z Kardiol (1978) 0.78
Letter: Sinus recovery time after disopyramide phosphate. Am J Cardiol (1976) 0.78
[Sinus node automaticity and sinoatrial conduction]. Z Kardiol (1975) 0.78
Circulatory and myocardial effects of different sodium antagonistic drugs in comparison to the calcium antagonist verapamil. Arzneimittelforschung (1989) 0.78
[Determination of systolic time intervals. A non-invasive method for evaluation of left ventricle function]. Dtsch Med Wochenschr (1980) 0.78
[Potentially dangerous adverse effects of anti-arrhythmia agents on the function of the sinus node]. Verh Dtsch Ges Inn Med (1976) 0.78
Preconditioning preserves energy metabolism in prolonged low-flow ischemia. Basic Res Cardiol (1998) 0.77
Effects of antiarrhythmic surgery on late ventricular potentials recorded by precordial signal averaging in patients with ventricular tachycardia. Am Heart J (1982) 0.77
[Diagnostic problems in the sinus node syndrome]. Z Kardiol (1975) 0.77
Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias. J Cardiovasc Pharmacol (1997) 0.77
[Effects of Atenolol and Propranolol on sinus node and intracardiac conduction in man (author's transl)]. Z Kardiol (1977) 0.77
Effect of right coronary artery occlusion during percutaneous transluminal coronary angioplasty on right ventricular performance. Am J Cardiol (1988) 0.77
Intraoperative electrophysiologic mapping during cardiac surgery. Thorac Cardiovasc Surg (1979) 0.77
Electrophysiologic effects of propafenone. Am Heart J (1984) 0.77
Negative inotropic effect of class-I-antiarrhythmic drugs: comparison of flecainide with disopyramide and quinidine. Eur Heart J (1987) 0.77
Myocardial and circulatory effects of inosine. Cardiovasc Res (1987) 0.77